Panic disorder - A condition for life? Treatment issues

Human Psychopharmacology

Volumn 12, Issue SUPPL. 1, 1997, Pages

  Westenberg, H G M ^a  

^a Academic Hospital Utrecht   (Netherlands)

Author keywords

Panic disorder; Pharmacotherapy; Psychotherapy; Treatment

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; BROFAROMINE; CLOMIPRAMINE; FLUVOXAMINE; IMIPRAMINE; MAPROTILINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; PHENELZINE; RITANSERIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

COGNITIVE THERAPY; CONFERENCE PAPER; DEPRESSION; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; HUMAN; NAUSEA; PANIC; PRIORITY JOURNAL; PSYCHOTHERAPY; SEXUAL DYSFUNCTION; SOMNOLENCE; SWEATING; VERTIGO; XEROSTOMIA;

EID: 0030838349     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199706)12:1+3.0.CO;2-H     Document Type: Conference Paper

References (23)

1. American Psychiatric Association (1980). DSM-III: Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. APA, Washington.
2. Ballenger, J. C. (1993). Panic disorder: efficacy of current treatments. Psychopharmacology Bulletin, 29, 477-486.
3. Black, D. W., Wesner, R., Bowers, W. and Gabel, J. (1993). A comparison of fluvoxamine, cognitive therapy and placebo in the treatment of panic disorder. Archives of General Psychiatry, 50, 44-50.
4. Boyer, W. (1995). Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. International Clinical Psychopharmacology, 10, 45-49.
5. Cassano, G. B., Petracca, A., Perugi, G., Nisita, C. and Musetti, L. (1988). Clomipramine for panic disorder I. The first 10 weeks of a long-term comparison with imipramine. Journal of Affective Disorders, 14, 123-127.
6. De Beurs, E., van Balkom, A. J. L. M., Lange, A., Koele, P. and van Dyck, R. (1995). Treatment of panic disorder with agoraphobia: comparison of fluvoxamine, placebo, and psychological panic management combined with exposure and of exposure in vivo alone. American Journal of Psychiatry, 152, 688-691.
7. den Boer, J. A. and Westenberg, H. G. M. (1988). Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder, a double-blind comparative study with fluvoxamine and maprotiline. International Clinical Psychopharmacology, 3, 59-74.
8. den Boer, J. A. and Westenberg, H. G. M. (1990). Serotonin function in panic disorder: a double-blind placebo-controlled study with fluvoxamine and ritanserin. Psychopharmacology, 102, 85-94.
9. den Boer, J. A., Westenberg, H. G. M., Kamerbeek, W. D. J., Verhoeven, W. M. and Kahn, R. S. (1987). Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. International Clinical Psychopharmacology, 2, 21-32.
10. Evans, L., Kenardy, J., Schneider, P. and Hoey, H. (1986). Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo. Acta Psychiatrica Scandinavica, 73, 49-53.
11. Hoehn-Saric, R., Fawcett, J., Munjack, D. J. and Roy-Byrne, P. P. (1994). A multi-centre, double-blind, placebo-controlled study of fluvoxamine in the treatment of panic disorder. Neuropsychopharmacology, 10 (Suppl. 3), 102S.
12. Jonas, J. M. and Cohon, M. S. (1993). A comparison of the safety and efficacy of alprazolam versus other agents in the treatment of anxiety, panic and depression: a review of the literature. Journal of Clinical Psychiatry, 54 (10, Suppl.), 25-45.
13. Kahn, R. S., Welzler, S., Asnis, G. M. and van Praag, H. M. (1990). The effects of m-chlorophenylpiperazine in normal subjects: a dose-response study. Psychopharmacology, 100, 339-344.
14. Klein, D. F. and Fink, M. (1962). Psychiatric reaction patterns to imipramine. American Journal of Psychiatry, 119, 432-438.
15. Klerman, G. L. (1992). Treatments for panic disorder. Journal of Clinical Psychiatry, 53 (3, Suppl.), 14-19.
16. Kumar, R. (1997). Setting new standards for the pharmacological treatment of panic disorder. Human Psychopharmacology, 12, S19-S26.
17. Lecrubier, Y., Bakker, A., Judge, R. and Collaborative Paroxetine Study Investigators (1997). A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Acta Psychiatrica Scandinavica, 95, 145-152.
18. Lenox, R. H., Shipley, J. E. and Peyser, J. M. (1984). Double-blind comparison of alprazolam vs imipramine in the inpatient treatment of major depressive illness. Psychopharmacology Bulletin, 20, 79-82.
19. McTavish, D. and Benfield, P. (1990). Clomipramine. An overview of its pharmacological properties and a review of its therapeutic use in obsessive compulsive disorder and panic disorder. Drugs, 39, 136-153.
20. Oehrberg, S., Christiansen, P. E., Behnke, K., Borup, A. L., Severin, B., Soegaard, J., Calberg, H., Judge, R., Ohrstrom, J. K. and Manniche, P. M. (1995). Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study. British Journal of Psychiatry, 167, 374-379.
21. Westenberg, H. G. M. and den Boer, J. A. (1991). Treatment of panic disorder: evidence supporting the role of serotonin. In: Serotonin, Sleep and Mental Disorder, Idziwoski, C. and Cowen, P. J. (Eds), Wrightson Biomedical Publishing Ltd, pp. 147-160.
22. Westenberg, H. G. M. and den Boer, J. A. (1993). New findings in the treatment of panic disorder. Pharmacopsychiatry, 26, 30-33.
23. Woods, S., Black, D., Brown, S., Asnis, G., Potkin, S., Hameedi, F. and Goddard, A. (1994). Fluvoxamine in the treatment of panic disorder in outpatients: a double-blind, placebo-controlled study. Neuropsychopharmacology, 10 (Suppl. 3), 103S.